Plasticell has successfully completed a collaboration with Stemnion, Inc., a Pittsburgh, PA-based biotechnology company focused on the applications of stem cells derived from human placentas. Plasticell used its flagship CombiCult technology to discover multiple novel, serum-free protocols that direct the differentiation of Stemnion’s stem cells into hard-to-obtain lineages. The protocols were ranked using Plasticell’s Ariadne bioinformatics software and subsequently validated by Stemnion scient...